Serum neurofilament light chain (sNfL)
Neurofilaments (Nfs), the main byproducts of neuroaxonal breakdown, are potential “universal” biomarkers of neurodegeneration.
We investigate serum (blood) neurofilament light chain (sNfL) as a potential biomarker for neurodegenearion, neural plasticity, and treatment response in neurological patients.
Facilities: Our Lab utilizes different serum analysis approaches, including single molecule array (SIMOA) platform (available now in the University of Cadiz) and new high-sensitive enzyme-linked immunosorbent assay (ELISA) method for human protein detection.
